Organogenesis Holdings Inc (ORGO) — Cash Flow Reinvestment Rate
Organogenesis Holdings Inc (ORGO) has a Cash Flow Reinvestment Rate of 1.45x as of September 2025, reinvesting $4.47 Million (capex $2.23 Million plus investments $-2.23 Million) from operating cash flow of $3.08 Million. Explore how much does Organogenesis Holdings Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Organogenesis Holdings Inc Cash Flow Reinvestment Rate (2020–2024)
Historical reinvestment intensity for Organogenesis Holdings Inc across 5 annual periods. Also explore total assets of Organogenesis Holdings Inc for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Organogenesis Holdings Inc (2020–2024)
Year-by-year capital reinvestment analysis for Organogenesis Holdings Inc. For live market cap and broader valuation context, see ORGO market cap.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.41x | $20.06 Million | $14.21 Million | $10.03 Million | ▼ -22.1% |
| 2023 | 1.81x | $56.06 Million | $30.92 Million | $24.36 Million | ▼ -33.5% |
| 2022 | 2.73x | $67.80 Million | $24.86 Million | $33.90 Million | ▲ +170.7% |
| 2021 | 1.01x | $62.44 Million | $61.98 Million | $31.22 Million | ▼ -87.0% |
| 2020 | 7.78x | $42.51 Million | $5.47 Million | $17.68 Million | — |